PMC9583524_01
Magnetic resonance cholangiopancreatography of upper abdomen showed a decreased liver uptake and bile duct excretion of Gd-EOB-DTPA. (A) hepatobiliary phase. (B) excretion period.
fmed-09-1033906-g0001.jpg
PMC9583524_01_fmed-09-1033906-g0001.jpg
F1
Resonance Cholangiopancreatography of upper abdomen showed a decreased liver uptake and bile duct excretion of Gd-EOB-DTPA, suggesting liver function impairment (Figure 1).
Changes of alanine aminotransferase (orange line, U/L) and total bilirubin (blue line, umol/L) during treatment. Arrow refers to plasma filtration adsorption.
fmed-09-1033906-g0002.jpg
PMC9583524_01_fmed-09-1033906-g0002.jpg
F2
Bilirubin decreased to baseline after 40 days (Figure 2).